WonderBrain Technologies
Early-stage Diagnostic Solution for Common Brain Disorders and Diseases
Company Overview
Snapshot
Founded in January 2022 by Yehonatan Roth, Adam Beck, and Nahum Cohen, WonderBrain Technologies operated with 1–10 employees. The company focused on developing a patented diagnostic solution for common brain disorders and diseases, reaching the clinical trial stage for its product.
Business overview
WonderBrain Technologies developed a stationary medical device designed for the early detection and diagnosis of common brain diseases such as Parkinson's, dementia, and Alzheimer's. The solution integrates innovative engineering, automation, and AI-driven software, based on medical research and clinical trials. Operating in the Health Tech & Life Sciences sector, specifically within Medical Devices and Diagnostics Devices, the company aimed to provide an affordable, accessible, non-invasive, and rapid diagnostic tool for healthcare providers, primarily serving the North American, European, and global markets.
Company Intelligence Q&A
- What is WonderBrain Technologies' primary focus?
- WonderBrain Technologies focuses on developing an early-stage diagnostic solution for common brain disorders and diseases, including Parkinson's, dementia, and Alzheimer's.
- When was WonderBrain Technologies founded?
- WonderBrain Technologies was founded in January 2022.
- Who are the founders of WonderBrain Technologies?
- The co-founders of WonderBrain Technologies are Yehonatan Roth, Adam Beck, and Nahum Cohen.
- What technology does WonderBrain Technologies utilize?
- WonderBrain Technologies' solution combines innovative engineering concepts, automation, and AI-driven software for its diagnostic device.
- What is the current status of WonderBrain Technologies?
- WonderBrain Technologies ceased to operate in July 2023.